WNX Warnex

On June 22, 2012, Warnex Inc. (TSX VENTURE:WNX) ("Warnex" or the "Company")
announced that it had received court approval to delay the date of its Annual
Meeting to a date which was to be no later than September 30, 2012. Such delay
was precipitated by the fact that as Warnex was advancing in its strategic
review process, it realized that such process may result in the requirement to
present various matters to its shareholders for approval, and that it would be
preferable that Warnex allow for the possibility of combining its Annual Meeting
with any other meeting of shareholders that may be required.


As Warnex continues to advance in its strategic review process, it has come to
the determination that it would be in the best interests of the Company to
further extend the deadline for the holding of its Annual Meeting to December
31, 2012. Accordingly, Warnex has obtained court approval to so extend such
deadline. A copy of such court approval may be obtained from Warnex upon
request.


However, Warnex cautions that there can be no assurance that its ongoing
strategic review process will result in any transaction, or, if a transaction is
realized, as to its terms or timing. Warnex's immediate priority remains
ensuring that its Bioanalytical division continues to maintain the highest
standards of service delivery for the benefit of its customers, its employees
and its other stakeholders.


Further announcements regarding the date for Warnex's Annual Meeting will be
made at the appropriate time.


About Warnex

Warnex (www.warnex.ca) is a life sciences company which, operating out of
facilities located in Laval, Quebec, specializes in bioequivalence and
bioavailability studies for clinical trials.


CAUTION REGARDING FORWARD-LOOKING STATEMENTS 

Certain statements contained in this news release are forward-looking and are
subject to numerous risks and uncertainties, known and unknown. For further
information identifying known risks and uncertainties, relating to financial
resources, liquidity risk, key customers and business partners, credit risk,
foreign currency risk, government regulations, laboratory facilities, volatility
of share price, employees, suppliers, and other important factors that could
cause actual results to differ materially from those anticipated in the
forward-looking statements, please refer to the heading Risks and Uncertainties
in Warnex's most recent Management's Discussion and Analysis, which can be found
at www.sedar.com. Consequently, actual results may differ materially from the
anticipated results expressed in these forward-looking statements.

Warnex (TSXV:WNX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Warnex (TSXV:WNX)
Historical Stock Chart
From Nov 2023 to Nov 2024